Allogeneic stem cell transplantation for the treatment of hematologic malignancies: Current indications and challenges

Journal of Rheumatology

Volumn 24, Issue SUPPL. 48, 1997, Pages 41-45

  Appelbaum, Frederick R ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Clinical Research Division   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Hematologic malignancies; Stem cell transplant

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CANCER ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; RADIOISOTOPE; RAPAMYCIN; TACROLIMUS; THALIDOMIDE; TRIMETREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ALLOIMMUNITY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONFERENCE PAPER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC SYSTEM TUMOR; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; ORGAN DONOR; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; ALLOTRANSPLANTATION; BLOOD DISEASE; DISEASE FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MALE; PATHOLOGY; PROGNOSIS; REVIEW; SURVIVAL RATE;

CLINICAL TRIALS; DISEASE-FREE SURVIVAL; FEMALE; GRAFT SURVIVAL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; PROGNOSIS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031138154     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Biggs JC, Horowitz MM, Gale RP, et al: Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 1992;80:1090-3.
2. Clift RA, Buckner CD, Appelbaum FR, et al: Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J Clin Oncol 1992;1723-9:
3. Zittoun R, Mandelli F, Willemze R, et al: EORTC-GIMEMA AML8 protocol. A phase III study on autologous bone-marrow transplantation in acute myelogenous leukemia. Leuk Lymphoma 1994;(suppl 1)13:101.
4. Barrett AJ, Horowitz MM, Pollock BH, et al: Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 1994;19:1253-8.
5. Fiere D, Lepage E, Sebban C, et al: Adult acute lymphoblastic leukemia: A multicentric randomized trial testing bone marrow transplantation as postremission therapy. J Clin Oncol 1993;11:1990-2001.
6. Anderson JE, Appelbaum FR, Fisher LD, et al: Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome. Blood 1993;82:677-81.
7. Thomas ED, Clift RA, Fefer A, et al: Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986;104:155-63.
8. Thomas ED, Clift RA: Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989;73:861-4.
9. Goldman JM, Szydlo R, Horowitz MM, et al: Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 1993;82:2235-8.
10. Buckner CD, Clift RA, Appelbaum FR, Thomas ED: Editorial: Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993;82:1954-6.
11. Philip T, Guglielmi C, Hagenbeek A, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995;333:1540-5.
12. Haioun C, Lepage E, Gisselbrecht C, et al: Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: A study of 464 patients. J Clin Oncol 1994;12:2543-51.
13. Verdonck LF, van Putten WL, Hagenbeek A, et al: Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med 1995;332:1045-51.
14. Chopra R, Goldstone AH, Pearce R, et al: Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: A case-controlled analysis of the European bone marrow transplant group registry data. J Clin Oncol 1992;10:1690-5.
15. Jagannath S, Armitage JO, Dicke KA, et al: Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol 1989;7:179-85.
16. Gahrton G, Tura S, Ljungman P, et al: Allogeneic bone marrow transplantation in multiple myeloma. N Engl J Med 1991;325:1267-73.
17. Bensinger WI, Buckner CD, Clift RA, et al: Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma. J Clin Oncol 1992;10:1492-7.
18. Beatty PG, Clift RA, Mickelson EM, et al: Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985;313:765-71.
19. Anasetti C, Amos D, Beatty PG, et al: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989;320:197-204.
20. Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER: Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 1980;303:565-7.
21. McCullough J, Hansen J, Perkins H, Stroncek D, Bartsch G: The National Marrow Donor Program: How it works, accomplishments to date. Oncology 1989;3:63-72.
22. Beatty PG, Hansen JA, Longton GM, et al: Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 1991;51:443-7.
23. Kernan NA, Bartsch G, Ash RC, et al: Analysis of 462 transplantations from unrelated donors facilitated by The National Marrow Donor Program. N Engl J Med 1993;328:593-602.
24. Kurtzberg J, Laughlin M, Graham ML, et al: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-66.
25. Slattery JT, Sanders JE, Buckner CD, et al: Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant 1995;16:31-42.
26. Clift RA, Bianco JA, Appelbaum FR, et al: A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation. Blood 1993;82:2025-30.
27. 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Blood 1995;85:1122-31.
28. Press OW, Eary JF, Badger CC, et al: Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol 1989;7:1027-38.
29. Press OW, Eary JF, Appelbaum FR, et al: Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 1993;329:1219-24.
30. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD: Restoration of viral immunity in immunocompromised humans by adoptive transfer of T-cell clones. Science 1992;257:238-41.
31. Walter EA, Greenberg PD, Gilbert MJ, et al: Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995;16:1033-44.